Recent advances in nuclear receptor-binding SET domain 2 (NSD2) inhibitors: An update and perspectives
Author:
Funder
Qinglan Project of Jiangsu Province of China
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference115 articles.
1. Diagnostic and prognostic epigenetic biomarkers in cancer;Costa-Pinheiro;Epigenomics,2015
2. The role of epigenomics in the study of cancer biomarkers and in the development of diagnostic tools;Verma;Adv. Exp. Med. Biol.,2015
3. Epigenetic therapies for cancer;Bates;N. Engl. J. Med.,2020
4. Understanding the language of Lys36 methylation at histone H3;Wagner;Nat. Rev. Mol. Cell Biol.,2012
5. Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function;Lucio-Eterovic;Proc. Natl. Acad. Sci. U. S. A.,2010
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. NSD family proteins: Rising stars as therapeutic targets;Cell Insight;2024-02
2. Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and in vitro and in vivo biological activity evaluations;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-12-07
3. Proteomics contributions to epigenetic drug discovery;PROTEOMICS;2023-09-19
4. Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2);Journal of Medicinal Chemistry;2023-08-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3